MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 4, Pages 3725-3731
Publisher
Wiley
Online
2017-12-13
DOI
10.1002/jcb.26595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway
- (2017) Bing Xu et al. Cancer Medicine
- The biological role of epithelial-mesenchymal transition in lung cancer (Review)
- (2016) Woo Jung Sung et al. ONCOLOGY REPORTS
- Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review
- (2015) Hui Cao et al. PATHOLOGY RESEARCH AND PRACTICE
- CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells
- (2015) Miao Mo et al. PLoS One
- CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer
- (2015) Yongqian Chen et al. TUMOR BIOLOGY
- CCR7 enhances TGF-β1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer
- (2015) Huiying Ma et al. Oncotarget
- CCL21/CCR7 axis activating chemotaxis accompanied with epithelial–mesenchymal transition in human breast carcinoma
- (2014) Fei Li et al. MEDICAL ONCOLOGY
- Expression of the C-C Chemokine Receptor 7 Mediates Metastasis of Breast Cancer to the Lymph Nodes in Mice
- (2014) Heather D. Cunningham et al. Translational Oncology
- The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer
- (2014) Cheng Peng et al. TUMOR BIOLOGY
- Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies
- (2011) Angela Hui et al. BMC CANCER
- NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA
- (2011) Feng Wang et al. CANCER LETTERS
- MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs
- (2011) Achim Aigner JOURNAL OF MOLECULAR MEDICINE-JMM
- MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer
- (2011) Jih-Hsiang Lee et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A MicroRNA Targeting Dicer for Metastasis Control
- (2010) Graziano Martello et al. CELL
- Many new down- and up-regulatory signaling pathways, from known cancer progression suppressors to matrix metalloproteinases, differ widely in cells of various cancers
- (2010) Gregory S. DeLassus et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
- (2010) Jun Yu et al. Molecular Cancer
- MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2
- (2010) Qingchuan Dong et al. PLoS One
- Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7
- (2009) Surabhi Dangi-Garimella et al. EMBO JOURNAL
- Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway
- (2009) Kun-Hung Shen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The microRNA network and tumor metastasis
- (2009) H Zhang et al. ONCOGENE
- Chemokine Receptor CCR7 Expression Correlates with Lymph Node Metastasis in Pancreatic Cancer
- (2008) Bunzo Nakata et al. ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started